{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:38:46Z","timestamp":1790519926117,"version":"4.1.0"},"reference-count":225,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T00:00:00Z","timestamp":1629936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1038\/s41581-021-00466-8","type":"journal-article","created":{"date-parts":[[2021,8,26]],"date-time":"2021-08-26T16:03:02Z","timestamp":1629993782000},"page":"795-813","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":55,"title":["Unconventional T cells and kidney disease"],"prefix":"10.1038","volume":"17","author":[{"given":"Hannah","family":"Kaminski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9213-6196","authenticated-orcid":false,"given":"Lionel","family":"Couzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9390-5348","authenticated-orcid":false,"given":"Matthias","family":"Eberl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,26]]},"reference":[{"key":"466_CR1","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/nri.2015.18","volume":"16","author":"M DuPage","year":"2016","unstructured":"DuPage, M. & Bluestone, J. A. Harnessing the plasticity of CD4+ T cells to treat immune-mediated disease. Nat. Rev. Immunol. 16, 149\u2013163 (2016).","journal-title":"Nat. Rev. Immunol."},{"key":"466_CR2","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00005-014-0293-y","volume":"62","author":"HW Mittr\u00fccker","year":"2014","unstructured":"Mittr\u00fccker, H. W., Visekruna, A. & Huber, M. Heterogeneity in the differentiation and function of CD8+ T cells. Arch. Immunol. Ther. Exp. 62, 449\u2013458 (2014).","journal-title":"Arch. Immunol. Ther. Exp."},{"key":"466_CR3","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1038\/ni.3298","volume":"16","author":"DI Godfrey","year":"2015","unstructured":"Godfrey, D. I., Uldrich, A. P., McCluskey, J., Rossjohn, J. & Moody, D. B. The burgeoning family of unconventional T cells. Nat. Immunol. 16, 1114\u20131123 (2015).","journal-title":"Nat. Immunol."},{"key":"466_CR4","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1038\/s41577-020-0345-y","volume":"20","author":"DG Pellicci","year":"2020","unstructured":"Pellicci, D. G., Koay, H. F. & Berzins, S. P. Thymic development of unconventional T cells: how NKT cells, MAIT cells and \u03b3\u03b4 T cells emerge. Nat. Rev. Immunol. 20, 756\u2013770 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"466_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1146\/annurev-immunol-041015-055435","volume":"34","author":"DA Rhodes","year":"2016","unstructured":"Rhodes, D. A., Reith, W. & Trowsdale, J. Regulation of immunity by butyrophilins. Annu. Rev. Immunol. 34, 151\u2013172 (2016).","journal-title":"Annu. Rev. Immunol."},{"key":"466_CR6","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1146\/annurev-immunol-102819-023144","volume":"38","author":"AC Hayday","year":"2020","unstructured":"Hayday, A. C. & Vantourout, P. The innate biologies of adaptive antigen receptors. Annu. Rev. Immunol. 38, 487\u2013510 (2020).","journal-title":"Annu. Rev. Immunol."},{"key":"466_CR7","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/s41590-019-0444-8","volume":"20","author":"DI Godfrey","year":"2019","unstructured":"Godfrey, D. I., Koay, H. F., McCluskey, J. & Gherardin, N. A. The biology and functional importance of MAIT cells. Nat. Immunol. 20, 1110\u20131128 (2019).","journal-title":"Nat. Immunol."},{"key":"466_CR8","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.3389\/fimmu.2020.01961","volume":"11","author":"AJ Corbett","year":"2020","unstructured":"Corbett, A. J., Awad, W., Wang, H. & Chen, Z. Antigen recognition by MR1-reactive T cells; MAIT cells, metabolites, and remaining mysteries. Front. Immunol. 11, 1961 (2020).","journal-title":"Front. Immunol."},{"key":"466_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coi.2013.09.005","volume":"26","author":"EJ Adams","year":"2014","unstructured":"Adams, E. J. Lipid presentation by human CD1 molecules and the diverse T cell populations that respond to them. Curr. Opin. Immunol. 26, 1\u20136 (2014).","journal-title":"Curr. Opin. Immunol."},{"key":"466_CR10","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.3389\/fimmu.2018.01365","volume":"9","author":"M Lepore","year":"2018","unstructured":"Lepore, M., Mori, L. & De Libero, G. The conventional nature of non-MHC-restricted T cells. Front. Immunol. 9, 1365 (2018).","journal-title":"Front. Immunol."},{"key":"466_CR11","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/imr.12928","volume":"298","author":"CR Willcox","year":"2020","unstructured":"Willcox, C. R., Mohammed, F. & Willcox, B. E. The distinct MHC-unrestricted immunobiology of innate-like and adaptive-like human \u03b3\u03b4 T cell subsets-Nature\u2019s CAR-T cells. Immunol. Rev. 298, 25\u201346 (2020).","journal-title":"Immunol. Rev."},{"key":"466_CR12","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/imr.12926","volume":"298","author":"M Papadopoulou","year":"2020","unstructured":"Papadopoulou, M., Sanchez Sanchez, G. & Vermijlen, D. Innate and adaptive \u03b3\u03b4 T cells: How, when, and why. Immunol. Rev. 298, 99\u2013116 (2020).","journal-title":"Immunol. Rev."},{"key":"466_CR13","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.immuni.2018.03.009","volume":"48","author":"DI Godfrey","year":"2018","unstructured":"Godfrey, D. I., Le Nours, J., Andrews, D. M., Uldrich, A. P. & Rossjohn, J. Unconventional T cell targets for cancer immunotherapy. Immunity 48, 453\u2013473 (2018).","journal-title":"Immunity"},{"key":"466_CR14","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41568-019-0153-5","volume":"19","author":"B Silva-Santos","year":"2019","unstructured":"Silva-Santos, B., Mensurado, S. & Coffelt, S. B. \u03b3\u03b4 T cells: pleiotropic immune effectors with therapeutic potential in cancer. Nat. Rev. Cancer 19, 392\u2013404 (2019).","journal-title":"Nat. Rev. Cancer"},{"key":"466_CR15","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1681\/ASN.2012010040","volume":"23","author":"JE Turner","year":"2012","unstructured":"Turner, J. E. et al. IL-17A production by renal \u03b3\u03b4 T cells promotes kidney injury in crescentic GN. J. Am. Soc. Nephrol. 23, 1486\u20131495 (2012). This study shows that in the mouse, kidney-resident \u03b3\u03b4 T cells produce IL-17A, promote neutrophil recruitment and contribute to the immunopathogenesis of crescentic glomerulonephritis.","journal-title":"J. Am. Soc. Nephrol."},{"key":"466_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26470-w","volume":"8","author":"T Uchida","year":"2018","unstructured":"Uchida, T. et al. Repeated administration of alpha-galactosylceramide ameliorates experimental lupus nephritis in mice. Sci. Rep. 8, 8225 (2018).","journal-title":"Sci. Rep."},{"key":"466_CR17","doi-asserted-by":"publisher","first-page":"572","DOI":"10.3389\/fimmu.2014.00572","volume":"5","author":"M Eberl","year":"2014","unstructured":"Eberl, M., Friberg, I. M., Liuzzi, A. R., Morgan, M. P. & Topley, N. Pathogen-specific immune fingerprints during acute infection: The diagnostic potential of human \u03b3\u03b4 T-cells. Front. Immunol. 5, 572 (2014).","journal-title":"Front. Immunol."},{"key":"466_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3389\/fimmu.2017.00105","volume":"8","author":"C Khairallah","year":"2017","unstructured":"Khairallah, C., D\u00e9chanet-Merville, J. & Capone, M. \u03b3\u03b4 T cell-mediated immunity to cytomegalovirus infection. Front. Immunol. 8, 105 (2017).","journal-title":"Front. Immunol."},{"key":"466_CR19","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/0923-2494(90)90068-A","volume":"141","author":"MP Lefranc","year":"1990","unstructured":"Lefranc, M. P. & Rabbitts, T. H. A nomenclature to fit the organization of the human T-cell receptor \u03b3 and \u03b4 genes. Res. Immunol. 141, 615\u2013618 (1990).","journal-title":"Res. Immunol."},{"key":"466_CR20","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/322836a0","volume":"322","author":"JS Heilig","year":"1986","unstructured":"Heilig, J. S. & Tonegawa, S. Diversity of murine gamma genes and expression in fetal and adult T lymphocytes. Nature 322, 836\u2013840 (1986).","journal-title":"Nature"},{"key":"466_CR21","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1111\/j.1600-065X.2006.00479.x","volume":"215","author":"CT Morita","year":"2007","unstructured":"Morita, C. T., Jin, C., Sarikonda, G. & Wang, H. Nonpeptide antigens, presentation mechanisms, and immunological memory of human V\u03b32V\u03b42 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens. Immunol. Rev. 215, 59\u201376 (2007).","journal-title":"Immunol. Rev."},{"key":"466_CR22","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/ki.1995.21","volume":"47","author":"MC Falk","year":"1995","unstructured":"Falk, M. C. et al. Infiltration of the kidney by \u03b1\u03b2 and \u03b3\u03b4 T cells: effect on progression in IgA nephropathy. Kidney Int. 47, 177\u2013185 (1995). This pioneering study shows that \u03b1\u03b2 T cells are found in both stable and progressive IgA nephropathy, whereas \u03b3\u03b4 T cells are associated with progressive IgA nephropathy.","journal-title":"Kidney Int."},{"key":"466_CR23","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1681\/ASN.2017060599","volume":"29","author":"JE Turner","year":"2018","unstructured":"Turner, J. E., Becker, M., Mittr\u00fccker, H. W. & Panzer, U. Tissue-resident lymphocytes in the kidney. J. Am. Soc. Nephrol. 29, 389\u2013399 (2018).","journal-title":"J. Am. Soc. Nephrol."},{"key":"466_CR24","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1182\/blood-2010-08-303339","volume":"117","author":"M Dusseaux","year":"2011","unstructured":"Dusseaux, M. et al. Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. Blood 117, 1250\u20131259 (2011).","journal-title":"Blood"},{"key":"466_CR25","first-page":"1","volume":"22","author":"I Nel","year":"2021","unstructured":"Nel, I., Bertrand, L., Toubal, A. & Lehuen, A. MAIT cells, guardians of skin and mucosa? Mucosal Immunol. 22, 1\u201312 (2021).","journal-title":"Mucosal Immunol."},{"key":"466_CR26","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1002\/eji.202048644","volume":"50","author":"ML Terpstra","year":"2020","unstructured":"Terpstra, M. L. et al. Tissue-resident mucosal-associated invariant T (MAIT) cells in the human kidney represent a functionally distinct subset. Eur. J. Immunol. 50, 1783\u20131797 (2020).","journal-title":"Eur. J. Immunol."},{"key":"466_CR27","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.molimm.2018.06.263","volume":"101","author":"F Gamb\u00f3n-Deza","year":"2018","unstructured":"Gamb\u00f3n-Deza, F. & Olivieri, D. N. Immunoglobulin and T cell receptor genes in Chinese crocodile lizard Shinisaurus crocodilurus. Mol. Immunol. 101, 160\u2013166 (2018).","journal-title":"Mol. Immunol."},{"key":"466_CR28","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/s41577-018-0007-5","volume":"18","author":"NL La Gruta","year":"2018","unstructured":"La Gruta, N. L., Gras, S., Daley, S. R., Thomas, P. G. & Rossjohn, J. Understanding the drivers of MHC restriction of T cell receptors. Nat. Rev. Immunol. 18, 467\u2013478 (2018).","journal-title":"Nat. Rev. Immunol."},{"key":"466_CR29","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nri2781","volume":"10","author":"M Bonneville","year":"2010","unstructured":"Bonneville, M., O\u2019Brien, R. L. & Born, W. K. \u03b3\u03b4 T cell effector functions: a blend of innate programming and acquired plasticity. Nat. Rev. Immunol. 10, 467\u2013478 (2010).","journal-title":"Nat. Rev. Immunol."},{"key":"466_CR30","doi-asserted-by":"publisher","first-page":"6697","DOI":"10.1073\/pnas.1909474117","volume":"117","author":"AS Fichtner","year":"2020","unstructured":"Fichtner, A. S. et al. Alpaca (Vicugna pacos), the first nonprimate species with a phosphoantigen-reactive V\u03b39V\u03b42 T cell subset. Proc. Natl Acad. Sci. USA 117, 6697\u20136707 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"466_CR31","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.semcdb.2017.10.009","volume":"84","author":"D Vermijlen","year":"2018","unstructured":"Vermijlen, D., Gatti, D., Kouzeli, A., Rus, T. & Eberl, M. \u03b3\u03b4 T cell responses: how many ligands will it take till we know? Semin. Cell Dev. Biol. 84, 75\u201386 (2018).","journal-title":"Semin. Cell Dev. Biol."},{"key":"466_CR32","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1038\/nri3889","volume":"15","author":"I Van Rhijn","year":"2015","unstructured":"Van Rhijn, I., Godfrey, D. I., Rossjohn, J. & Moody, D. B. Lipid and small-molecule display by CD1 and MR1. Nat. Rev. Immunol. 15, 643\u2013654 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"466_CR33","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S0014-5793(01)03191-X","volume":"509","author":"M Hintz","year":"2001","unstructured":"Hintz, M. et al. Identification of (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate as a major activator for human \u03b3\u03b4 T cells in Escherichia coli. FEBS Lett. 509, 317\u2013322 (2001).","journal-title":"FEBS Lett."},{"key":"466_CR34","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nature13160","volume":"509","author":"AJ Corbett","year":"2014","unstructured":"Corbett, A. J. et al. T-cell activation by transitory neo-antigens derived from distinct microbial pathways. Nature 509, 361\u2013365 (2014). This study identifies simple adducts between microbial vitamin B2 precursors and small intracellular molecules such as methylglyoxal as the most potent ligands for MAIT cells that are stabilized by covalent binding to MR1.","journal-title":"Nature"},{"key":"466_CR35","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/S0014-5793(03)00483-6","volume":"544","author":"M Eberl","year":"2003","unstructured":"Eberl, M. et al. Microbial isoprenoid biosynthesis and human \u03b3\u03b4 T cell activation. FEBS Lett. 544, 4\u201310 (2003).","journal-title":"FEBS Lett."},{"key":"466_CR36","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1099\/mic.0.051599-0","volume":"158","author":"S Heuston","year":"2012","unstructured":"Heuston, S., Begley, M., Gahan, C. G. M. & Hill, C. Isoprenoid biosynthesis in bacterial pathogens. Microbiology 158, 1389\u20131401 (2012).","journal-title":"Microbiology"},{"key":"466_CR37","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1182\/blood-2012-05-430470","volume":"120","author":"C Harly","year":"2012","unstructured":"Harly, C. et al. Key implication of CD277\/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human \u03b3\u03b4 T-cell subset. Blood 120, 2269\u20132279 (2012).","journal-title":"Blood"},{"key":"466_CR38","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.immuni.2014.03.003","volume":"40","author":"A Sandstrom","year":"2014","unstructured":"Sandstrom, A. et al. The intracellular B30.2 domain of butyrophilin 3A1 binds phosphoantigens to mediate activation of human V\u03b39V\u03b42 T cells. Immunity 40, 490\u2013500 (2014).","journal-title":"Immunity"},{"key":"466_CR39","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.immuni.2020.02.014","volume":"52","author":"MM Karunakaran","year":"2020","unstructured":"Karunakaran, M. M. et al. Butyrophilin-2A1 directly binds germline-encoded regions of the V\u03b39V\u03b42 TCR and is essential for phosphoantigen sensing. Immunity 52, 487\u2013498.e6 (2020). This is one of two seminal studies that identifies the butyrophilin BTN2A1 as the ligand for human V\u03b39V\u03b42 Tcells and proposes a model of how V\u03b39V\u03b42 T cells respond to phosphoantigens in the context of BTN2A1 and BTN3A1.","journal-title":"Immunity"},{"key":"466_CR40","doi-asserted-by":"publisher","DOI":"10.1126\/science.aay5516","volume":"367","author":"M Rigau","year":"2020","unstructured":"Rigau, M. et al. Butyrophilin 2A1 is essential for phosphoantigen reactivity by \u03b3\u03b4 T cells. Science. 367, eaay5516 (2020). This is one of two seminal studies that identify the butyrophilin BTN2A1 as the ligand for human V\u03b39V\u03b42 Tcells and propose a model of how V\u03b39V\u03b42 T cells respond to phosphoantigens in the context of BTN2A1 and BTN3A1.","journal-title":"Science."},{"key":"466_CR41","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41573-019-0038-z","volume":"19","author":"Z Sebestyen","year":"2020","unstructured":"Sebestyen, Z., Prinz, I., D\u00e9chanet-Merville, J., Silva-Santos, B. & Kuball, J. Translating gammadelta (\u03b3\u03b4) T cells and their receptors into cancer cell therapies. Nat. Rev. Drug Discov. 19, 169\u2013184 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"466_CR42","doi-asserted-by":"publisher","first-page":"4637","DOI":"10.1172\/JCI132489","volume":"130","author":"A Vyborova","year":"2020","unstructured":"Vyborova, A. et al. \u03b39\u03b42T cell diversity and the receptor interface with tumor cells. J. Clin. Invest. 130, 4637\u20134651 (2020).","journal-title":"J. Clin. Invest."},{"key":"466_CR43","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.coi.2015.06.002","volume":"36","author":"AR Liuzzi","year":"2015","unstructured":"Liuzzi, A. R., McLaren, J. E., Price, D. A. & Eberl, M. Early innate responses to pathogens: pattern recognition by unconventional human T-cells. Curr. Opin. Immunol. 36, 31\u201337 (2015).","journal-title":"Curr. Opin. Immunol."},{"key":"466_CR44","doi-asserted-by":"publisher","first-page":"3704","DOI":"10.4049\/jimmunol.1401018","volume":"193","author":"MS Davey","year":"2014","unstructured":"Davey, M. S. et al. Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J. Immunol. 193, 3704\u20133716 (2014).","journal-title":"J. Immunol."},{"key":"466_CR45","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abc9492","volume":"5","author":"LJ Howson","year":"2020","unstructured":"Howson, L. J. et al. Absence of mucosal-associated invariant T cells in a person with a homozygous point mutation in MR1. Sci. Immunol. 5, eabc9492 (2020).","journal-title":"Sci. Immunol."},{"key":"466_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10198-w","volume":"10","author":"HF Koay","year":"2019","unstructured":"Koay, H. F. et al. Diverse MR1-restricted T cells in mice and humans. Nat. Commun. 10, 2243 (2019).","journal-title":"Nat. Commun."},{"key":"466_CR47","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.molimm.2020.12.009","volume":"130","author":"M Lepore","year":"2021","unstructured":"Lepore, M., Lewinsohn, D. A. & Lewinsohn, D. M. T cell receptor diversity, specificity and promiscuity of functionally heterogeneous human MR1-restricted T cells. Mol. Immunol. 130, 64\u201368 (2021).","journal-title":"Mol. Immunol."},{"key":"466_CR48","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.3389\/fimmu.2018.01266","volume":"9","author":"Y Kinjo","year":"2018","unstructured":"Kinjo, Y. et al. Functions of CD1d-restricted invariant natural killer T cells in antimicrobial immunity and potential applications for infection control. Front. Immunol. 9, 1266 (2018).","journal-title":"Front. Immunol."},{"key":"466_CR49","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1021\/jm00012a018","volume":"38","author":"M Morita","year":"1995","unstructured":"Morita, M. et al. Structure-activity relationship of \u03b1-galactosylceramides against B16-bearing mice. J. Med. Chem. 38, 2176\u20132187 (1995).","journal-title":"J. Med. Chem."},{"key":"466_CR50","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1146\/annurev-immunol-032414-112008","volume":"34","author":"L Mori","year":"2016","unstructured":"Mori, L., Lepore, M. & De Libero, G. The Immunology of CD1- and MR1-restricted T cells. Annu. Rev. Immunol. 34, 479\u2013510 (2016).","journal-title":"Annu. Rev. Immunol."},{"key":"466_CR51","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.4049\/jimmunol.1601399","volume":"198","author":"MV Dhodapkar","year":"2017","unstructured":"Dhodapkar, M. V. & Kumar, V. Type II NKT cells and their emerging role in health and disease. J. Immunol. 198, 1015\u20131021 (2017).","journal-title":"J. Immunol."},{"key":"466_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms13257","volume":"7","author":"S Gras","year":"2016","unstructured":"Gras, S. et al. T cell receptor recognition of CD1b presenting a mycobacterial glycolipid. Nat. Commun. 7, 13257 (2016).","journal-title":"Nat. Commun."},{"key":"466_CR53","doi-asserted-by":"publisher","first-page":"E4648","DOI":"10.1073\/pnas.1408549111","volume":"111","author":"S Roy","year":"2014","unstructured":"Roy, S. et al. Molecular basis of mycobacterial lipid antigen presentation by CD1c and its recognition by \u03b1\u03b2 T cells. Proc. Natl Acad. Sci. US A 111, E4648\u2013E4657 (2014).","journal-title":"Proc. Natl Acad. Sci. US A"},{"key":"466_CR54","doi-asserted-by":"publisher","first-page":"4499","DOI":"10.4049\/jimmunol.1301660","volume":"191","author":"AG Kasmar","year":"2013","unstructured":"Kasmar, A. G. et al. Cutting edge: CD1a tetramers and dextramers identify human lipopeptide-specific T cells ex vivo. J. Immunol. 191, 4499\u20134503 (2013).","journal-title":"J. Immunol."},{"key":"466_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1086\/314568","volume":"179","author":"J D\u00e9chanet","year":"1999","unstructured":"D\u00e9chanet, J. et al. Major expansion of \u03b3\u03b4 T lymphocytes following cytomegalovirus infection in kidney allograft recipients. J. Infect. Dis. 179, 1\u20138 (1999).","journal-title":"J. Infect. Dis."},{"key":"466_CR56","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1172\/JCI5409","volume":"103","author":"J D\u00e9chanet","year":"1999","unstructured":"D\u00e9chanet, J. et al. Implication of \u03b3\u03b4 T cells in the human immune response to cytomegalovirus. J. Clin. Invest. 103, 1437\u20131449 (1999). The first study to show that human V\u03b42neg \u03b3\u03b4 Tcells expand in the peripheral blood of kidney transplant recipients after CMV infection and have an important role in the immune response against this virus.","journal-title":"J. Clin. Invest."},{"key":"466_CR57","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1084\/jem.20090348","volume":"207","author":"D Vermijlen","year":"2010","unstructured":"Vermijlen, D. et al. Human cytomegalovirus elicits fetal \u03b3\u03b4 T cell responses in utero. J. Exp. Med. 207, 807\u2013821 (2010).","journal-title":"J. Exp. Med."},{"key":"466_CR58","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1038\/ni.2394","volume":"13","author":"CR Willcox","year":"2012","unstructured":"Willcox, C. R. et al. Cytomegalovirus and tumor stress surveillance by binding of a human \u03b3\u03b4 T cell antigen receptor to endothelial protein C receptor. Nat. Immunol. 13, 872\u2013879 (2012).","journal-title":"Nat. Immunol."},{"key":"466_CR59","doi-asserted-by":"publisher","first-page":"3163","DOI":"10.1073\/pnas.1621052114","volume":"114","author":"R Marlin","year":"2017","unstructured":"Marlin, R. et al. Sensing of cell stress by human \u03b3\u03b4 TCR-dependent recognition of annexin A2. Proc. Natl Acad. Sci. USA 114, 3163\u20133168 (2017).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"466_CR60","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1002\/eji.201270101","volume":"42","author":"B Silva-Santos","year":"2012","unstructured":"Silva-Santos, B., Schamel, W. W., Fisch, P. & Eberl, M. \u03b3\u03b4 T-cell conference 2012: close encounters for the fifth time. Eur. J. Immunol. 42, 3101\u20133105 (2012).","journal-title":"Eur. J. Immunol."},{"key":"466_CR61","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.cellimm.2014.11.001","volume":"296","author":"M Bonneville","year":"2015","unstructured":"Bonneville, M. et al. Chicago 2014 \u2013 30 years of \u03b3\u03b4 T cells. Cell Immunol. 296, 3\u20139 (2015).","journal-title":"Cell Immunol."},{"key":"466_CR62","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.cell.2016.08.030","volume":"167","author":"R Di Marco Barros","year":"2016","unstructured":"Di Marco Barros, R. et al. Epithelia use butyrophilin-like molecules to shape organ-specific \u03b3\u03b4 T cell compartments. Cell 167, 203\u2013218.e17 (2016).","journal-title":"Cell"},{"key":"466_CR63","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.cell.2018.12.039","volume":"176","author":"T Mayassi","year":"2019","unstructured":"Mayassi, T. et al. Chronic inflammation permanently reshapes tissue-resident immunity in celiac disease. Cell 176, 967\u2013981.e19 (2019).","journal-title":"Cell"},{"key":"466_CR64","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3390\/pathogens7020053","volume":"7","author":"SW Tuffs","year":"2018","unstructured":"Tuffs, S. W., Haeryfar, S. M. M. & McCormick, J. K. Manipulation of innate and adaptive immunity by staphylococcal superantigens. Pathogens 7, 53 (2018).","journal-title":"Pathogens"},{"key":"466_CR65","doi-asserted-by":"publisher","first-page":"6144","DOI":"10.3390\/ijms21176144","volume":"21","author":"FR Shepherd","year":"2020","unstructured":"Shepherd, F. R. & McLaren, J. E. T cell immunity to bacterial pathogens: mechanisms of immune control and bacterial evasion. Int. J. Mol. Sci. 21, 6144 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"466_CR66","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3389\/fimmu.2018.00929","volume":"9","author":"AE Sim\u00f5es","year":"2018","unstructured":"Sim\u00f5es, A. E., Di Lorenzo, B. & Silva-Santos, B. Molecular determinants of target cell recognition by human \u03b3\u03b4 T cells. Front. Immunol. 9, 929 (2018).","journal-title":"Front. Immunol."},{"key":"466_CR67","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/JLB.4RI0118-023R","volume":"104","author":"PT Rudak","year":"2018","unstructured":"Rudak, P. T., Choi, J. & Haeryfar, S. M. M. MAIT cell-mediated cytotoxicity: roles in host defense and therapeutic potentials in infectious diseases and cancer. J. Leukoc. Biol. 104, 473\u2013486 (2018).","journal-title":"J. Leukoc. Biol."},{"key":"466_CR68","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1146\/annurev-biochem-011520-102754","volume":"89","author":"Z Djaoud","year":"2020","unstructured":"Djaoud, Z. & Parham, P. HLAs, TCRs, and KIRs, a triumvirate of human cell-mediated immunity. Annu. Rev. Biochem. 89, 717\u2013739 (2020).","journal-title":"Annu. Rev. Biochem."},{"key":"466_CR69","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1007\/s00018-011-0699-1","volume":"68","author":"D Wesch","year":"2011","unstructured":"Wesch, D., Peters, C., Oberg, H. H., Pietschmann, K. & Kabelitz, D. Modulation of \u03b3\u03b4 T cell responses by TLR ligands. Cell Mol. Life Sci. 68, 2357\u20132370 (2011).","journal-title":"Cell Mol. Life Sci."},{"key":"466_CR70","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.3389\/fimmu.2018.01478","volume":"9","author":"LC Garner","year":"2018","unstructured":"Garner, L. C., Klenerman, P. & Provine, N. M. Insights into mucosal-associated invariant T cell biology from studies of invariant natural killer T cells. Front. Immunol. 9, 1478 (2018).","journal-title":"Front. Immunol."},{"key":"466_CR71","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1146\/annurev-immunol-080719-015428","volume":"38","author":"NM Provine","year":"2020","unstructured":"Provine, N. M. & Klenerman, P. MAIT cells in health and disease. Annu. Rev. Immunol. 38, 203\u2013228 (2020).","journal-title":"Annu. Rev. Immunol."},{"key":"466_CR72","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cellimm.2015.01.008","volume":"296","author":"CJ Tyler","year":"2015","unstructured":"Tyler, C. J., Doherty, D. G., Moser, B. & Eberl, M. Human V\u03b39\/V\u03b42 T cells: innate adaptors of the immune system. Cell Immunol. 296, 10\u201321 (2015).","journal-title":"Cell Immunol."},{"key":"466_CR73","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.jaut.2017.11.006","volume":"87","author":"PH Papotto","year":"2018","unstructured":"Papotto, P. H., Reinhardt, A., Prinz, I. & Silva-Santos, B. Innately versatile: \u03b3\u03b417 T cells in inflammatory and autoimmune diseases. J. Autoimmun. 87, 26\u201337 (2018).","journal-title":"J. Autoimmun."},{"key":"466_CR74","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1002\/eji.202048645","volume":"50","author":"MM Pisarska","year":"2020","unstructured":"Pisarska, M. M., Dunne, M. R., O\u2019Shea, D. & Hogan, A. E. Interleukin-17 producing mucosal associated invariant T cells - emerging players in chronic inflammatory diseases? Eur. J. Immunol. 50, 1098\u20131108 (2020).","journal-title":"Eur. J. Immunol."},{"key":"466_CR75","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.it.2011.07.003","volume":"32","author":"R Houot","year":"2011","unstructured":"Houot, R., Kohrt, H. E., Marabelle, A. & Levy, R. Targeting immune effector cells to promote antibody-induced cytotoxicity in cancer immunotherapy. Trends Immunol. 32, 510\u2013516 (2011).","journal-title":"Trends Immunol."},{"key":"466_CR76","doi-asserted-by":"publisher","first-page":"3956","DOI":"10.1111\/bph.13845","volume":"174","author":"T Kyaw","year":"2017","unstructured":"Kyaw, T. et al. Cytotoxic lymphocytes and atherosclerosis: significance, mechanisms and therapeutic challenges. Br. J. Pharmacol. 174, 3956\u20133972 (2017).","journal-title":"Br. J. Pharmacol."},{"key":"466_CR77","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1126\/science.1110267","volume":"309","author":"M Brandes","year":"2005","unstructured":"Brandes, M., Willimann, K. & Moser, B. Professional antigen-presentation function by human \u03b3\u03b4 T cells. Science 309, 264\u2013268 (2005).","journal-title":"Science"},{"key":"466_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-02886-8","volume":"7","author":"M Barisa","year":"2017","unstructured":"Barisa, M. et al. E. coli promotes human V\u03b39V\u03b42\u2009T cell transition from cytokine-producing bactericidal effectors to professional phagocytic killers in a TCR-dependent manner. Sci. Rep. 7, 2805 (2017).","journal-title":"Sci. Rep."},{"key":"466_CR79","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41590-020-00847-4","volume":"22","author":"C Junqueira","year":"2021","unstructured":"Junqueira, C. et al. \u03b3\u03b4 T cells suppress Plasmodium falciparum blood-stage infection by direct killing and phagocytosis. Nat. Immunol. 22, 347\u2013357 (2021).","journal-title":"Nat. Immunol."},{"key":"466_CR80","doi-asserted-by":"publisher","first-page":"686","DOI":"10.3390\/cells9030686","volume":"9","author":"MD Johnson","year":"2020","unstructured":"Johnson, M. D., Witherden, D. A. & Havran, W. L. The role of tissue-resident T cells in stress surveillance and tissue maintenance. Cells 9, 686 (2020).","journal-title":"Cells"},{"key":"466_CR81","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1038\/s41590-018-0094-2","volume":"19","author":"AC Kohlgruber","year":"2018","unstructured":"Kohlgruber, A. C. et al. \u03b3\u03b4 T cells producing interleukin-17A regulate adipose regulatory T cell homeostasis and thermogenesis. Nat. Immunol. 19, 464\u2013474 (2018).","journal-title":"Nat. Immunol."},{"key":"466_CR82","doi-asserted-by":"publisher","DOI":"10.1126\/science.aba8310","volume":"371","author":"ZA Sullivan","year":"2021","unstructured":"Sullivan, Z. A. et al. \u03b3\u03b4 T cells regulate the intestinal response to nutrient sensing. Science 371, eaba8310 (2021).","journal-title":"Science"},{"key":"466_CR83","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/bs.ai.2015.07.005","volume":"128","author":"Z Carico","year":"2015","unstructured":"Carico, Z. & Krangel, M. S. Chromatin dynamics and the development of the TCR\u03b1 and TCR\u03b4 repertoires. Adv. Immunol. 128, 307\u2013361 (2015).","journal-title":"Adv. Immunol."},{"key":"466_CR84","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.cellimm.2015.02.010","volume":"296","author":"CD Pauza","year":"2015","unstructured":"Pauza, C. D. & Cairo, C. Evolution and function of the TCR V\u03b39 chain repertoire: it\u2019s good to be public. Cell Immunol. 296, 22\u201330 (2015).","journal-title":"Cell Immunol."},{"key":"466_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04076-0","volume":"9","author":"MS Davey","year":"2018","unstructured":"Davey, M. S. et al. The human V\u03b42+ T-cell compartment comprises distinct innate-like V\u03b39+ and adaptive V\u03b39\u2212 subsets. Nat. Commun. 9, 1760 (2018).","journal-title":"Nat. Commun."},{"key":"466_CR86","doi-asserted-by":"publisher","first-page":"18638","DOI":"10.1073\/pnas.1922595117","volume":"117","author":"M Papadopoulou","year":"2020","unstructured":"Papadopoulou, M. et al. Fetal public V\u03b39V\u03b42 T cells expand and gain potent cytotoxic functions early after birth. Proc. Natl Acad. Sci. USA 117, 18638\u201318648 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"466_CR87","doi-asserted-by":"publisher","first-page":"18649","DOI":"10.1073\/pnas.1922588117","volume":"117","author":"S Ravens","year":"2020","unstructured":"Ravens, S. et al. Microbial exposure drives polyclonal expansion of innate \u03b3\u03b4 T cells immediately after birth. Proc. Natl Acad. Sci. USA 117, 18649\u201318660 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"466_CR88","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14760","volume":"8","author":"MS Davey","year":"2017","unstructured":"Davey, M. S. et al. Clonal selection in the human V\u03b41 T cell repertoire indicates \u03b3\u03b4 TCR-dependent adaptive immune surveillance. Nat. Commun. 8, 14760 (2017).","journal-title":"Nat. Commun."},{"key":"466_CR89","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1038\/ni.3686","volume":"18","author":"S Ravens","year":"2017","unstructured":"Ravens, S. et al. Human \u03b3\u03b4 T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infection. Nat. Immunol. 18, 393\u2013401 (2017). The first study to show rapid expansion of CMV-reactive \u03b3\u03b4 TCR clonotypes in patients receiving haematopoietic stem cell transplants, which is strong evidence of an adaptive \u03b3\u03b4 T cell response.","journal-title":"Nat. Immunol."},{"key":"466_CR90","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/imm.12247","volume":"142","author":"V Kumar","year":"2014","unstructured":"Kumar, V. & Delovitch, T. L. Different subsets of natural killer T cells may vary in their roles in health and disease. Immunology 142, 321\u2013336 (2014).","journal-title":"Immunology"},{"key":"466_CR91","doi-asserted-by":"publisher","first-page":"6305439","DOI":"10.1155\/2017\/6305439","volume":"2017","author":"A Kezi\u0107","year":"2017","unstructured":"Kezi\u0107, A., Stajic, N. & Thaiss, F. Innate immune response in kidney ischemia\/reperfusion injury: potential target for therapy. J. Immunol. Res. 2017, 6305439 (2017).","journal-title":"J. Immunol. Res."},{"key":"466_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-018-2094-x","volume":"22","author":"I G\u00f6cze","year":"2018","unstructured":"G\u00f6cze, I. et al. Postoperative cellular stress in the kidney is associated with an early systemic \u03b3\u03b4 T-cell immune cell response. Crit. Care 22, 168 (2018).","journal-title":"Crit. Care"},{"key":"466_CR93","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-019-2022-0","volume":"17","author":"C Zhu","year":"2019","unstructured":"Zhu, C. et al. Kidney injury in response to crystallization of calcium oxalate leads to rearrangement of the intrarenal T cell receptor delta immune repertoire. J. Transl. Med. 17, 278 (2019).","journal-title":"J. Transl. Med."},{"key":"466_CR94","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/sj.ki.5000038","volume":"69","author":"V Savransky","year":"2006","unstructured":"Savransky, V. et al. Role of the T-cell receptor in kidney ischemia-reperfusion injury. Kidney Int. 69, 233\u2013238 (2006). This study suggests that murine \u03b3\u03b4 T cells can facilitate and amplify kidney lesions after IRI by recruiting adaptive \u03b1\u03b2 T cells.","journal-title":"Kidney Int."},{"key":"466_CR95","doi-asserted-by":"publisher","first-page":"F741","DOI":"10.1152\/ajprenal.00486.2006","volume":"293","author":"K Hochegger","year":"2007","unstructured":"Hochegger, K. et al. Role of \u03b1\/\u03b2 and \u03b3\/\u03b4 T cells in renal ischemia-reperfusion injury. Am. J. Physiol. Ren. Physiol 293, F741\u2013F747 (2007).","journal-title":"Am. J. Physiol. Ren. Physiol"},{"key":"466_CR96","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1681\/ASN.2009121217","volume":"22","author":"JD Bauerle","year":"2011","unstructured":"Bauerle, J. D., Grenz, A., Kim, J. H., Lee, H. T. & Eltzschig, H. K. Adenosine generation and signaling during acute kidney injury. J. Am. Soc. Nephrol. 22, 14\u201320 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"466_CR97","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1084\/jem.20061097","volume":"203","author":"CM Lappas","year":"2006","unstructured":"Lappas, C. M., Day, Y. J., Marshall, M. A., Engelhard, V. H. & Linden, J. Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation. J. Exp. Med. 203, 2639\u20132648 (2006).","journal-title":"J. Exp. Med."},{"key":"466_CR98","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1681\/ASN.2014121248","volume":"27","author":"J Zhang","year":"2016","unstructured":"Zhang, J. et al. Hypoxia-inducible factor-2\u03b1 limits natural killer T cell cytotoxicity in fenal ischemia\/reperfusion injury. J. Am. Soc. Nephrol. 27, 92\u2013106 (2016). This study shows that HIF2\u03b1 is induced in iNKT cells during hypoxia and enhances the protective effect of adenosine by suppressing iNKT cell activation during IRI.","journal-title":"J. Am. Soc. Nephrol."},{"key":"466_CR99","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1172\/JCI63170","volume":"122","author":"L Li","year":"2012","unstructured":"Li, L. et al. Dendritic cells tolerized with adenosine A2AR agonist attenuate acute kidney injury. J. Clin. Invest. 122, 3931\u20133942 (2012). This study shows that during ischaemia\u2013reperfusion, DCs loaded with \u03b1-GalCer and tolerized by adenosine receptor agonists inhibit IFN\u03b3 production by iNKT, and thereby limit IRI in the kidney.","journal-title":"J. Clin. Invest."},{"key":"466_CR100","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1681\/ASN.2010080815","volume":"22","author":"SH Yang","year":"2011","unstructured":"Yang, S. H. et al. Sulfatide-reactive natural killer T cells abrogate ischemia-reperfusion injury. J. Am. Soc. Nephrol. 22, 1305\u20131314 (2011). This study shows that type II NKT cells protect mouse kidneys from experimental IRI lesions and attenuated the apoptosis of kidney tubule cells via IL-10 in vitro.","journal-title":"J. Am. Soc. Nephrol."},{"key":"466_CR101","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-014-0224-z","volume":"12","author":"C Zhang","year":"2014","unstructured":"Zhang, C. et al. Rapamycin protects kidney against ischemia reperfusion injury through recruitment of NKT cells. J. Transl. Med. 12, 224 (2014).","journal-title":"J. Transl. Med."},{"key":"466_CR102","unstructured":"Yu, A., et al. Brenner and Rector\u2019s The Kidney, 2-Volume Set 11th edn (Elsevier, 2019)."},{"key":"466_CR103","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1056\/NEJMra1206793","volume":"368","author":"RJ Wyatt","year":"2013","unstructured":"Wyatt, R. J. & Julian, B. A. IgA nephropathy. N. Engl. J. Med. 368, 2402\u20132414 (2013).","journal-title":"N. Engl. J. Med."},{"key":"466_CR104","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/ki.1997.427","volume":"52","author":"C Olive","year":"1997","unstructured":"Olive, C. et al. Expression of the mucosal \u03b3\u03b4 T cell receptor V region repertoire in patients with IgA nephropathy. Kidney Int. 52, 1047\u20131053 (1997).","journal-title":"Kidney Int."},{"key":"466_CR105","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1365-2249.2002.01784.x","volume":"127","author":"KS Buck","year":"2002","unstructured":"Buck, K. S. et al. Expression of T cell receptor variable region families by bone marrow \u03b3\u03b4 T cells in patients with IgA nephropathy. Clin. Exp. Immunol. 127, 527\u2013532 (2002).","journal-title":"Clin. Exp. Immunol."},{"key":"466_CR106","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1046\/j.1365-2249.2001.01494.x","volume":"124","author":"S Toyabe","year":"2001","unstructured":"Toyabe, S., Harada, W. & Uchiyama, M. Oligoclonally expanding \u03b3\u03b4 T lymphocytes induce IgA switching in IgA nephropathy. Clin. Exp. Immunol. 124, 110\u2013117 (2001).","journal-title":"Clin. Exp. Immunol."},{"key":"466_CR107","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1046\/j.1523-1755.2001.00937.x","volume":"60","author":"H Wu","year":"2001","unstructured":"Wu, H., Clarkson, A. R. & Knight, J. F. Restricted \u03b3\u03b4 T-cell receptor repertoire in IgA nephropathy renal biopsies. Kidney Int. 60, 1324\u20131331 (2001).","journal-title":"Kidney Int."},{"key":"466_CR108","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41584-018-0145-y","volume":"15","author":"D Nakazawa","year":"2019","unstructured":"Nakazawa, D., Masuda, S., Tomaru, U. & Ishizu, A. Pathogenesis and therapeutic interventions for ANCA-associated vasculitis. Nat. Rev. Rheumatol. 15, 91\u2013101 (2019).","journal-title":"Nat. Rev. Rheumatol."},{"key":"466_CR109","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1681\/ASN.2008050556","volume":"20","author":"HJ Paust","year":"2009","unstructured":"Paust, H. J. et al. The IL-23\/Th17 axis contributes to renal injury in experimental glomerulonephritis. J. Am. Soc. Nephrol. 20, 969\u2013979 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"466_CR110","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1111\/cei.13058","volume":"191","author":"B Fazekas","year":"2018","unstructured":"Fazekas, B. et al. Alterations in circulating lymphoid cell populations in systemic small vessel vasculitis are non-specific manifestations of renal injury. Clin. Exp. Immunol. 191, 180\u2013188 (2018).","journal-title":"Clin. Exp. Immunol."},{"key":"466_CR111","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1681\/ASN.2006111286","volume":"18","author":"C Holm\u00e9n","year":"2007","unstructured":"Holm\u00e9n, C. et al. Anti endothelial cell autoantibodies selectively activate SAPK\/JNK signalling in Wegener\u2019s granulomatosis. J. Am. Soc. Nephrol. 18, 2497\u20132508 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"466_CR112","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1046\/j.1523-1755.2000.00263.x","volume":"58","author":"AR Rosenkranz","year":"2000","unstructured":"Rosenkranz, A. R. et al. Regulatory interactions of \u03b1\u03b2 and \u03b3\u03b4 T cells in glomerulonephritis. Kidney Int. 58, 1055\u20131066 (2000). This pioneering study shows that \u03b3\u03b4 T cell-deficient mice display fewer CD8+ T cells and macrophages in the kidneys than wild-type mice, suggesting that \u03b3\u03b4 T cells have the ability to recruit these cells into the kidney interstitium.","journal-title":"Kidney Int."},{"key":"466_CR113","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1016\/j.immuni.2016.10.020","volume":"45","author":"CF Krebs","year":"2016","unstructured":"Krebs, C. F. et al. Autoimmune renal disease is exacerbated by S1P-receptor-1-dependent intestinal Th17 cell migration to the kidney. Immunity 45, 1078\u20131092 (2016).","journal-title":"Immunity"},{"key":"466_CR114","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.4049\/jimmunol.1602025","volume":"199","author":"PY Gan","year":"2017","unstructured":"Gan, P. Y. et al. Pathogenic role for \u03b3\u03b4 T cells in autoimmune anti-myeloperoxidase glomerulonephritis. J. Immunol. 199, 3042\u20133050 (2017).","journal-title":"J. Immunol."},{"key":"466_CR115","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1681\/ASN.2007101117","volume":"19","author":"SH Yang","year":"2008","unstructured":"Yang, S. H. et al. NKT cells inhibit the development of experimental crescentic glomerulonephritis. J. Am. Soc. Nephrol. 19, 1663\u20131671 (2008). This study shows that murine type II NKT cells ameliorate glomerular lesions in experimental crescentic glomerulonephritis, and inhibit lipopolysaccharide-induced proliferation of mesangial cells in vitro.","journal-title":"J. Am. Soc. Nephrol."},{"key":"466_CR116","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1681\/ASN.2008040433","volume":"20","author":"L Mesnard","year":"2009","unstructured":"Mesnard, L. et al. Invariant natural killer T cells and TGF-\u03b2 attenuate anti-GBM glomerulonephritis. J. Am. Soc. Nephrol. 20, 1282\u20131292 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"466_CR117","doi-asserted-by":"publisher","first-page":"1987","DOI":"10.1681\/ASN.2012040394","volume":"23","author":"JH Riedel","year":"2012","unstructured":"Riedel, J. H. et al. Immature renal dendritic cells recruit regulatory CXCR6+ invariant natural killer T cells to attenuate crescentic GN. J. Am. Soc. Nephrol. 23, 1987\u20132000 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"466_CR118","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.autrev.2012.09.003","volume":"12","author":"M Gatto","year":"2013","unstructured":"Gatto, M. et al. Emerging and critical issues in the pathogenesis of lupus. Autoimmun. Rev. 12, 523\u2013536 (2013).","journal-title":"Autoimmun. Rev."},{"key":"466_CR119","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1365-3083.2012.02705.x","volume":"76","author":"L Wang","year":"2012","unstructured":"Wang, L. et al. Downregulation of CD94\/NKG2A inhibitory receptor on decreased \u03b3\u03b4 T cells in patients with systemic lupus erythematosus. Scand. J. Immunol. 76, 62\u201369 (2012).","journal-title":"Scand. J. Immunol."},{"key":"466_CR120","doi-asserted-by":"publisher","first-page":"6693","DOI":"10.4049\/jimmunol.1002776","volume":"186","author":"X Li","year":"2011","unstructured":"Li, X. et al. Generation of human regulatory \u03b3\u03b4 T cells by TCR\u03b3\u03b4 stimulation in the presence of TGF-\u03b2 and their involvement in the pathogenesis of systemic lupus erythematosus. J. Immunol. 186, 6693\u20136700 (2011).","journal-title":"J. Immunol."},{"key":"466_CR121","doi-asserted-by":"publisher","first-page":"5689","DOI":"10.4049\/jimmunol.157.12.5689","volume":"157","author":"SL Peng","year":"1996","unstructured":"Peng, S. L., Madaio, M. P., Hayday, A. C. & Craft, J. Propagation and regulation of systemic autoimmunity by \u03b3\u03b4 T cells. J. Immunol. 157, 5689\u20135698 (1996).","journal-title":"J. Immunol."},{"key":"466_CR122","doi-asserted-by":"publisher","first-page":"7020","DOI":"10.1073\/pnas.87.18.7020","volume":"87","author":"S Rajagopalan","year":"1990","unstructured":"Rajagopalan, S., Zordan, T., Tsokos, G. C. & Datta, S. K. Pathogenic anti-DNA autoantibody-inducing T helper cell lines from patients with active lupus nephritis: isolation of CD4-8- T helper cell lines that express the \u03b3\u03b4 T-cell antigen receptor. Proc. Natl Acad. Sci. USA 87, 7020\u20137024 (1990).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"466_CR123","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05487-9","volume":"9","author":"RM Rezende","year":"2018","unstructured":"Rezende, R. M. et al. \u03b3\u03b4 T cells control humoral immune response by inducing T follicular helper cell differentiation. Nat. Commun. 9, 3151 (2018). In this study, CXCR5+ murine \u03b3\u03b4 T cells are shown to induce TFH cell differentiation, enhance autoantibody production and thereby promote the development of lupus nephritis.","journal-title":"Nat. Commun."},{"key":"466_CR124","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1681\/ASN.2015101077","volume":"27","author":"JH Riedel","year":"2016","unstructured":"Riedel, J. H. et al. IL-17F promotes tissue injury in autoimmune kidney diseases. J. Am. Soc. Nephrol. 27, 3666\u20133677 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"466_CR125","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s10875-011-9590-y","volume":"32","author":"JQ Yang","year":"2012","unstructured":"Yang, J. Q., Kim, P. J. & Singh, R. R. Brief treatment with iNKT cell ligand \u03b1-galactosylceramide confers a long-term protection against lupus. J. Clin. Immunol. 32, 106\u2013113 (2012).","journal-title":"J. Clin. Immunol."},{"key":"466_CR126","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1002\/art.22490","volume":"56","author":"JQ Yang","year":"2007","unstructured":"Yang, J. Q. et al. Examining the role of CD1d and natural killer T cells in the development of nephritis in a genetically susceptible lupus model. Arthritis Rheum. 56, 1219\u20131233 (2007).","journal-title":"Arthritis Rheum."},{"key":"466_CR127","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.4049\/jimmunol.171.6.2873","volume":"171","author":"LM Esteban","year":"2003","unstructured":"Esteban, L. M. et al. Genetic control of NKT cell numbers maps to major diabetes and lupus loci. J. Immunol. 171, 2873\u20132878 (2003).","journal-title":"J. Immunol."},{"key":"466_CR128","doi-asserted-by":"publisher","first-page":"3740","DOI":"10.4049\/jimmunol.167.7.3740","volume":"167","author":"T Ando","year":"2001","unstructured":"Ando, T. et al. Infiltration of canonical V\u03b34\/V\u03b41 \u03b3\u03b4 T cells in an adriamycin-induced progressive renal failure model. J. Immunol. 167, 3740\u20133745 (2001).","journal-title":"J. Immunol."},{"key":"466_CR129","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1681\/ASN.2006060622","volume":"18","author":"H Wu","year":"2007","unstructured":"Wu, H. et al. Depletion of \u03b3\u03b4 T cells exacerbates murine adriamycin nephropathy. J. Am. Soc. Nephrol. 18, 1180\u20131189 (2007).","journal-title":"J. Am. Soc. Nephrol."},{"key":"466_CR130","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/eji.200838741","volume":"39","author":"C Koenecke","year":"2009","unstructured":"Koenecke, C. et al. In vivo application of mAb directed against the \u03b3\u03b4 TCR does not deplete but generates \u201cinvisible\u201d \u03b3\u03b4 T cells. Eur. J. Immunol. 39, 372\u2013379 (2009).","journal-title":"Eur. J. Immunol."},{"key":"466_CR131","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1002\/eji.200324780","volume":"34","author":"H Wu","year":"2004","unstructured":"Wu, H., Knight, J. F. & Alexander, S. I. Regulatory \u03b3\u03b4 T cells in Heymann nephritis express an invariant V\u03b36\/V\u03b41 with a canonical CDR3 sequence. Eur. J. Immunol. 34, 2322\u20132330 (2004).","journal-title":"Eur. J. Immunol."},{"key":"466_CR132","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/kisup.2014.20","volume":"4","author":"T Kawakami","year":"2014","unstructured":"Kawakami, T., Mimura, I., Shoji, K., Tanaka, T. & Nangaku, M. Hypoxia and fibrosis in chronic kidney disease: crossing at pericytes. Kidney Int. Suppl. 4, 107\u2013112 (2014).","journal-title":"Kidney Int. Suppl."},{"key":"466_CR133","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/path.4430","volume":"235","author":"X Peng","year":"2015","unstructured":"Peng, X. et al. IL-17A produced by both \u03b3\u03b4 T and Th17 cells promotes renal fibrosis via RANTES-mediated leukocyte infiltration after renal obstruction. J. Pathol. 235, 79\u201389 (2015).","journal-title":"J. Pathol."},{"key":"466_CR134","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1093\/ndt\/gfy098","volume":"34","author":"BM Law","year":"2019","unstructured":"Law, B. M. et al. Effector \u03b3\u03b4 T cells in human renal fibrosis and chronic kidney disease. Nephrol. Dial. Transpl. 34, 40\u201348 (2019).","journal-title":"Nephrol. Dial. Transpl."},{"key":"466_CR135","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1681\/ASN.2018101064","volume":"30","author":"BMP Law","year":"2019","unstructured":"Law, B. M. P. et al. Human tissue-resident mucosal-associated invariant T (MAIT) cells in renal fibrosis and CKD. J. Am. Soc. Nephrol. 30, 1322\u20131335 (2019). This study shows that human MAIT cells infiltrate kidney tissue with tubulo-interstitial fibrosis and induce proximal tubule epithelial cell necrosis via perforin and granzyme B in vitro.","journal-title":"J. Am. Soc. Nephrol."},{"key":"466_CR136","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.semnephrol.2019.10.006","volume":"39","author":"MM Ullah","year":"2019","unstructured":"Ullah, M. M. & Basile, D. P. Role of renal hypoxia in the progression from acute kidney injury to chronic kidney disease. Semin. Nephrol. 39, 567\u2013580 (2019).","journal-title":"Semin. Nephrol."},{"key":"466_CR137","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1093\/ndt\/gfy035","volume":"33","author":"F Locatelli","year":"2018","unstructured":"Locatelli, F., Carfagna, F., Del Vecchio, L. & La Milia, V. Haemodialysis or haemodiafiltration: that is the question. Nephrol. Dial. Transpl. 33, 1896\u20131904 (2018).","journal-title":"Nephrol. Dial. Transpl."},{"key":"466_CR138","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1053\/j.ackd.2018.10.005","volume":"26","author":"L Kumbar","year":"2019","unstructured":"Kumbar, L. & Yee, J. Current concepts in hemodialysis vascular access infections. Adv. Chronic Kidney Dis. 26, 16\u201322 (2019).","journal-title":"Adv. Chronic Kidney Dis."},{"key":"466_CR139","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1093\/ndt\/gfy276","volume":"35","author":"T Cr\u00e9pin","year":"2020","unstructured":"Cr\u00e9pin, T. et al. Uraemia-induced immune senescence and clinical outcomes in chronic kidney disease patients. Nephrol. Dial. Transpl. 35, 624\u2013632 (2020).","journal-title":"Nephrol. Dial. Transpl."},{"key":"466_CR140","doi-asserted-by":"publisher","first-page":"597","DOI":"10.7326\/0003-4819-93-4-597","volume":"93","author":"SE Goldblum","year":"1980","unstructured":"Goldblum, S. E. & Reed, W. P. Host defenses and immunologic alterations associated with chronic hemodialysis. Ann. Intern. Med. 93, 597\u2013613 (1980).","journal-title":"Ann. Intern. Med."},{"key":"466_CR141","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/sj.ki.5001550","volume":"70","author":"JW Yoon","year":"2006","unstructured":"Yoon, J. W., Gollapudi, S., Pahl, M. V. & Vaziri, N. D. Na\u00efve and central memory T-cell lymphopenia in end-stage renal disease. Kidney Int. 70, 371\u2013376 (2006).","journal-title":"Kidney Int."},{"key":"466_CR142","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1093\/ndt\/13.11.2861","volume":"13","author":"Y Matsumoto","year":"1998","unstructured":"Matsumoto, Y. et al. Peripheral deletion of \u03b3\u03b4 T cells in haemodialysis patients. Nephrol. Dial. Transpl. 13, 2861\u20132866 (1998).","journal-title":"Nephrol. Dial. Transpl."},{"key":"466_CR143","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1046\/j.1442-200X.2002.01501.x","volume":"44","author":"M Szczep\u00e1nska","year":"2002","unstructured":"Szczep\u00e1nska, M., Szprynger, K., Mazur, B. & Szczep\u00e1nski, T. \u03b1\u03b2 and \u03b3\u03b4 T cell subsets in chronic renal failure in children on dialysis treatment. Pediatr. Int. 44, 32\u201336 (2002).","journal-title":"Pediatr. Int."},{"key":"466_CR144","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1016\/j.kint.2017.03.036","volume":"92","author":"JA Juno","year":"2017","unstructured":"Juno, J. A. et al. \u03b3\u03b4 T-cell function is inhibited in end-stage renal disease and impacted by latent tuberculosis infection. Kidney Int. 92, 1003\u20131014 (2017).","journal-title":"Kidney Int."},{"key":"466_CR145","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105422","volume":"9","author":"M Baron","year":"2014","unstructured":"Baron, M. et al. Innate-like and conventional T cell populations from hemodialyzed and kidney transplanted patients are equally compromised. PLoS ONE 9, e105422 (2014).","journal-title":"PLoS ONE"},{"key":"466_CR146","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.3389\/fimmu.2018.01076","volume":"9","author":"JA Juno","year":"2018","unstructured":"Juno, J. A. et al. Mucosal-associated invariant T cells are depleted and exhibit altered chemokine receptor expression and elevated granulocyte macrophage-colony stimulating factor production during end-stage renal disease. Front. Immunol. 9, 1076 (2018).","journal-title":"Front. Immunol."},{"key":"466_CR147","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1093\/ndt\/gft495","volume":"29","author":"K Peukert","year":"2014","unstructured":"Peukert, K. et al. Invariant natural killer T cells are depleted in renal impairment and recover after kidney transplantation. Nephrol. Dial. Transpl. 29, 1020\u20131028 (2014).","journal-title":"Nephrol. Dial. Transpl."},{"key":"466_CR148","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1038\/nrneph.2011.135","volume":"7","author":"F Schaefer","year":"2011","unstructured":"Schaefer, F. & Warady, B. A. Peritoneal dialysis in children with end-stage renal disease. Nat. Rev. Nephrol. 7, 659\u2013668 (2011).","journal-title":"Nat. Rev. Nephrol."},{"key":"466_CR149","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nrneph.2016.181","volume":"13","author":"PK Li","year":"2017","unstructured":"Li, P. K. et al. Changes in the worldwide epidemiology of peritoneal dialysis. Nat. Rev. Nephrol. 13, 90\u2013103 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"466_CR150","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.kint.2017.02.037","volume":"92","author":"C Aufricht","year":"2017","unstructured":"Aufricht, C. et al. Biomarker research to improve clinical outcomes of peritoneal dialysis: consensus of the European Training and Research in Peritoneal Dialysis (EuTRiPD) network. Kidney Int. 92, 824\u2013835 (2017).","journal-title":"Kidney Int."},{"key":"466_CR151","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1177\/089686089601600412","volume":"16","author":"MG Betjes","year":"1996","unstructured":"Betjes, M. G. et al. Intraperitoneal interleukin-8 and neutrophil influx in the initial phase of a CAPD peritonitis. Perit. Dial. Int. 16, 385\u2013392 (1996).","journal-title":"Perit. Dial. Int."},{"key":"466_CR152","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.4049\/jimmunol.1600990","volume":"197","author":"AR Liuzzi","year":"2016","unstructured":"Liuzzi, A. R. et al. Unconventional human T cells accumulate at the site of infection in response to microbial ligands and induce local tissue remodeling. J. Immunol. 197, 2195\u20132207 (2016).","journal-title":"J. Immunol."},{"key":"466_CR153","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.kint.2016.10.030","volume":"91","author":"CT Liao","year":"2017","unstructured":"Liao, C. T. et al. Peritoneal macrophage heterogeneity is associated with different peritoneal dialysis outcomes. Kidney Int. 91, 1088\u20131103 (2017).","journal-title":"Kidney Int."},{"key":"466_CR154","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1009071","volume":"17","author":"RJ Burton","year":"2021","unstructured":"Burton, R. J., Ahmed, R., Cuff, S. M., Artemiou, A. & Eberl, M. CytoPy: an autonomous cytometry analysis framework. PLoS Comput. Biol. 17, e1009071 (2021).","journal-title":"PLoS Comput. Biol."},{"key":"466_CR155","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1038\/ki.1996.195","volume":"49","author":"H Fricke","year":"1996","unstructured":"Fricke, H. et al. Continuous ambulatory peritoneal dialysis impairs T lymphocyte selection in the peritoneum. Kidney Int. 49, 1386\u20131395 (1996).","journal-title":"Kidney Int."},{"key":"466_CR156","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1000308","volume":"5","author":"M Eberl","year":"2009","unstructured":"Eberl, M. et al. A rapid crosstalk of human \u03b3\u03b4 T cells and monocytes drives the acute inflammation in bacterial infections. PLoS Pathog. 5, e1000308 (2009).","journal-title":"PLoS Pathog."},{"key":"466_CR157","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002040","volume":"7","author":"MS Davey","year":"2011","unstructured":"Davey, M. S. et al. Human neutrophil clearance of bacterial pathogens triggers anti-microbial \u03b3\u03b4 T cell responses in early infection. PLoS Pathog. 7, e1002040 (2011).","journal-title":"PLoS Pathog."},{"key":"466_CR158","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/ki.2014.33","volume":"86","author":"R Rodrigues-D\u00edez","year":"2014","unstructured":"Rodrigues-D\u00edez, R. et al. IL-17A is a novel player in dialysis-induced peritoneal damage. Kidney Int. 86, 303\u2013315 (2014).","journal-title":"Kidney Int."},{"key":"466_CR159","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.jcmgh.2020.01.003","volume":"9","author":"O Ibidapo-Obe","year":"2020","unstructured":"Ibidapo-Obe, O. et al. Mucosal-associated invariant T cells redistribute to the peritoneal cavity during spontaneous bacterial peritonitis and contribute to peritoneal inflammation. Cell Mol. Gastroenterol. Hepatol. 9, 661\u2013677 (2020).","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"key":"466_CR160","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1002\/hep.31153","volume":"72","author":"CE Niehaus","year":"2020","unstructured":"Niehaus, C. E. et al. MAIT cells are enriched and highly functional in ascites of patients with decompensated liver cirrhosis. Hepatology 72, 1378\u20131393 (2020).","journal-title":"Hepatology"},{"key":"466_CR161","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1093\/ndt\/gfs612","volume":"28","author":"CY Lin","year":"2013","unstructured":"Lin, C. Y., Kift-Morgan, A., Moser, B., Topley, N. & Eberl, M. Suppression of pro-inflammatory T-cell responses by human mesothelial cells. Nephrol. Dial. Transpl. 28, 1743\u20131750 (2013).","journal-title":"Nephrol. Dial. Transpl."},{"key":"466_CR162","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","volume":"341","author":"RA Wolfe","year":"1999","unstructured":"Wolfe, R. A. et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N. Engl. J. Med. 341, 1725\u20131730 (1999).","journal-title":"N. Engl. J. Med."},{"key":"466_CR163","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1600-6143.2011.03840.x","volume":"12","author":"J Sellar\u00e9s","year":"2012","unstructured":"Sellar\u00e9s, J. et al. Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence. Am. J. Transpl. 12, 388\u2013399 (2012).","journal-title":"Am. J. Transpl."},{"key":"466_CR164","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1111\/j.1600-6143.2010.03074.x","volume":"10","author":"A Humar","year":"2010","unstructured":"Humar, A. et al. The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients. Am. J. Transpl. 10, 1228\u20131237 (2010).","journal-title":"Am. J. Transpl."},{"key":"466_CR165","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/TP.0b013e318238dab3","volume":"93","author":"O Witzke","year":"2012","unstructured":"Witzke, O. et al. Valganciclovir prophylaxis versus preemptive therapy in cytomegalovirus-positive renal allograft recipients: 1-year results of a randomized clinical trial. Transplantation 93, 61\u201368 (2012).","journal-title":"Transplantation"},{"key":"466_CR166","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1128\/CMR.00034-08","volume":"22","author":"T Crough","year":"2009","unstructured":"Crough, T. & Khanna, R. Immunobiology of human cytomegalovirus: from bench to bedside. Clin. Microbiol. Rev. 22, 76\u201398 (2009).","journal-title":"Clin. Microbiol. Rev."},{"key":"466_CR167","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1086\/644509","volume":"200","author":"L Couzi","year":"2009","unstructured":"Couzi, L. et al. Common features of \u03b3\u03b4 T cells and CD8+ \u03b1\u03b2 T cells responding to human cytomegalovirus infection in kidney transplant recipients. J. Infect. Dis. 200, 1415\u20131424 (2009).","journal-title":"J. Infect. Dis."},{"key":"466_CR168","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1038\/leu.2012.374","volume":"27","author":"W Scheper","year":"2013","unstructured":"Scheper, W. et al. \u03b3\u03b4T cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemia. Leukemia 27, 1328\u20131338 (2013).","journal-title":"Leukemia"},{"key":"466_CR169","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1111\/j.1432-2277.2010.01181.x","volume":"24","author":"L Couzi","year":"2011","unstructured":"Couzi, L. et al. Gamma-delta T cell expansion is closely associated with cytomegalovirus infection in all solid organ transplant recipients. Transpl. Int. 24, e40\u2013e42 (2011).","journal-title":"Transpl. Int."},{"key":"466_CR170","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1182\/blood-2008-01-136713","volume":"112","author":"V Pitard","year":"2008","unstructured":"Pitard, V. et al. Long-term expansion of effector\/memory V\u03b42\u2212\u03b3\u03b4 T cells is a specific blood signature of CMV infection. Blood 112, 1317\u20131324 (2008).","journal-title":"Blood"},{"key":"466_CR171","first-page":"jiaa400","volume":"5","author":"H Kaminski","year":"2020","unstructured":"Kaminski, H. et al. Characterization of a unique \u03b3\u03b4 T cell subset as a specific marker of CMV infection severity. J. Infect. Dis. 5, jiaa400 (2020).","journal-title":"J. Infect. Dis."},{"key":"466_CR172","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.cellimm.2013.07.009","volume":"284","author":"M Pistillo","year":"2013","unstructured":"Pistillo, M. et al. The effects of age and viral serology on \u03b3\u03b4 T-cell numbers and exercise responsiveness in humans. Cell Immunol. 284, 91\u201397 (2013).","journal-title":"Cell Immunol."},{"key":"466_CR173","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1182\/blood-2011-06-363655","volume":"119","author":"L Couzi","year":"2012","unstructured":"Couzi, L. et al. Antibody-dependent anti-cytomegalovirus activity of human \u03b3\u03b4 T cells expressing CD16 (Fc\u03b3RIIIa). Blood 119, 1418\u20131427 (2012). This study identifies a new antiviral function for CMV-induced CD16+ human \u03b3\u03b4 T cells through cooperation with anti-CMV IgG that contributes to surveillance of CMV reactivation in solid organ transplant recipients.","journal-title":"Blood"},{"key":"466_CR174","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1084\/jem.20041851","volume":"201","author":"F Halary","year":"2005","unstructured":"Halary, F. et al. Shared reactivity of V\u03b42neg \u03b3\u03b4 T cells against cytomegalovirus-infected cells and tumor intestinal epithelial cells. J. Exp. Med. 201, 1567\u20131578 (2005).","journal-title":"J. Exp. Med."},{"key":"466_CR175","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004702","volume":"11","author":"C Khairallah","year":"2015","unstructured":"Khairallah, C. et al. \u03b3\u03b4 T cells confer protection against murine cytomegalovirus (MCMV). PLoS Pathog. 11, e1004702 (2015).","journal-title":"PLoS Pathog."},{"key":"466_CR176","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004481","volume":"11","author":"S Sell","year":"2015","unstructured":"Sell, S. et al. Control of murine cytomegalovirus infection by \u03b3\u03b4 T cells. PLoS Pathog. 11, e1004481 (2015).","journal-title":"PLoS Pathog."},{"key":"466_CR177","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1681\/ASN.2014100985","volume":"27","author":"H Kaminski","year":"2016","unstructured":"Kaminski, H. et al. Surveillance of \u03b3\u03b4 T cells predicts cytomegalovirus infection resolution in kidney transplants. J. Am. Soc. Nephrol. 27, 637\u2013645 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"466_CR178","doi-asserted-by":"publisher","first-page":"2789","DOI":"10.1002\/eji.200939414","volume":"39","author":"J Renneson","year":"2009","unstructured":"Renneson, J. et al. IL-12 and type I IFN response of neonatal myeloid DC to human CMV infection. Eur. J. Immunol. 39, 2789\u20132799 (2009).","journal-title":"Eur. J. Immunol."},{"key":"466_CR179","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2014.1003011","volume":"4","author":"F Guerville","year":"2015","unstructured":"Guerville, F. et al. TCR-dependent sensitization of human \u03b3\u03b4 T cells to non-myeloid IL-18 in cytomegalovirus and tumor stress surveillance. Oncoimmunology 4, e1003011 (2015).","journal-title":"Oncoimmunology"},{"key":"466_CR180","doi-asserted-by":"publisher","first-page":"582","DOI":"10.3389\/fimmu.2016.00582","volume":"7","author":"J Marino","year":"2016","unstructured":"Marino, J., Paster, J. & Benichou, G. Allorecognition by T lymphocytes and allograft rejection. Front. Immunol. 7, 582 (2016).","journal-title":"Front. Immunol."},{"key":"466_CR181","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3389\/fimmu.2018.00275","volume":"9","author":"CC Chen","year":"2018","unstructured":"Chen, C. C. et al. T cell help is mandatory for naive and memory donor-specific antibody responses: Impact of therapeutic immunosuppression. Front. Immunol. 9, 275 (2018).","journal-title":"Front. Immunol."},{"key":"466_CR182","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1111\/j.1600-6143.2009.02819.x","volume":"9","author":"X Zhang","year":"2009","unstructured":"Zhang, X. & Reed, E. F. Effect of antibodies on endothelium. Am. J. Transpl. 9, 2459\u20132465 (2009).","journal-title":"Am. J. Transpl."},{"key":"466_CR183","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1681\/ASN.2013101144","volume":"26","author":"A Sicard","year":"2015","unstructured":"Sicard, A. et al. Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss. J. Am. Soc. Nephrol. 26, 457\u2013467 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"466_CR184","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1111\/j.1600-6143.2010.03201.x","volume":"10","author":"LG Hidalgo","year":"2010","unstructured":"Hidalgo, L. G. et al. NK cell transcripts and NK cells in kidney biopsies from patients with donor-specific antibodies: evidence for NK cell involvement in antibody-mediated rejection. Am. J. Transpl. 10, 1812\u20131822 (2010).","journal-title":"Am. J. Transpl."},{"key":"466_CR185","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1053\/bbmt.1999.v5.pm10465102","volume":"5","author":"WR Drobyski","year":"1999","unstructured":"Drobyski, W. R., Majewski, D. & Hanson, G. Graft-facilitating doses of ex vivo activated \u03b3\u03b4 T cells do not cause lethal murine graft-vs.-host disease. Biol. Blood Marrow Transpl. 5, 222\u2013230 (1999).","journal-title":"Biol. Blood Marrow Transpl."},{"key":"466_CR186","doi-asserted-by":"publisher","first-page":"2415374","DOI":"10.1155\/2020\/2415374","volume":"2020","author":"Z Zhang","year":"2020","unstructured":"Zhang, Z. et al. Identifying 4 Novel lncRNAs as potential biomarkers for acute rejection and graft loss of renal allograft. J. Immunol. Res. 2020, 2415374 (2020).","journal-title":"J. Immunol. Res."},{"key":"466_CR187","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aav4036","volume":"3","author":"PM Benveniste","year":"2018","unstructured":"Benveniste, P. M. et al. Generation and molecular recognition of melanoma-associated antigen-specific human \u03b3\u03b4 T cells. Sci. Immunol. 3, eaav4036 (2018).","journal-title":"Sci. Immunol."},{"key":"466_CR188","doi-asserted-by":"publisher","first-page":"S187","DOI":"10.1161\/CIRCULATIONAHA.110.014852","volume":"124","author":"S Itoh","year":"2011","unstructured":"Itoh, S. et al. Interleukin-17 accelerates allograft rejection by suppressing regulatory T cell expansion. Circulation 124, S187\u2013S196 (2011). The first study to show that in the mouse, \u03b3\u03b4 T cells are a potential source of IL-17, which is crucial for promoting acute allograft rejection by inhibiting the expansion of Treg cells.","journal-title":"Circulation"},{"key":"466_CR189","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1016\/j.jid.2017.03.043","volume":"137","author":"Y Li","year":"2017","unstructured":"Li, Y. et al. V\u03b34 \u03b3\u03b4 T cells provide an early source of IL-17a and accelerate skin graft rejection. J. Invest. Dermatol. 137, 2513\u20132522 (2017).","journal-title":"J. Invest. Dermatol."},{"key":"466_CR190","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1038\/jid.2012.16","volume":"132","author":"A Rahimpour","year":"2012","unstructured":"Rahimpour, A. et al. \u03b3\u03b4 T cells augment rejection of skin grafts by enhancing cross-priming of CD8 T cells to skin-derived antigen. J. Invest. Dermatol. 132, 1656\u20131664 (2012).","journal-title":"J. Invest. Dermatol."},{"key":"466_CR191","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1111\/ajt.15898","volume":"20","author":"A Loupy","year":"2020","unstructured":"Loupy, A. et al. The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell- and antibody-mediated rejection. Am. J. Transpl. 20, 2318\u20132331 (2020).","journal-title":"Am. J. Transpl."},{"key":"466_CR192","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1681\/ASN.2013101052","volume":"25","author":"T Bachelet","year":"2014","unstructured":"Bachelet, T. et al. Cytomegalovirus-responsive \u03b3\u03b4 T cells: novel effector cells in antibody-mediated kidney allograft microcirculation lesions. J. Am. Soc. Nephrol. 25, 2471\u20132482 (2014). An important study showing that CMV-induced CD16+ human \u03b3\u03b4 T cells can perform antibody-dependent cellular cytotoxicity against donor cells coated with donor-specific antibodies, supporting the notion that these cells are involved in antibody-mediated injury of kidney transplants.","journal-title":"J. Am. Soc. Nephrol."},{"key":"466_CR193","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1111\/j.1600-6143.2006.01621.x","volume":"7","author":"M Mart\u00ednez-Llordella","year":"2007","unstructured":"Mart\u00ednez-Llordella, M. et al. Multiparameter immune profiling of operational tolerance in liver transplantation. Am. J. Transpl. 7, 309\u2013319 (2007).","journal-title":"Am. J. Transpl."},{"key":"466_CR194","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1097\/TP.0b013e3182782f9f","volume":"95","author":"X Zhao","year":"2013","unstructured":"Zhao, X. et al. Intragraft V\u03b41 \u03b3\u03b4 T cells with a unique T-cell receptor are closely associated with pediatric semiallogeneic liver transplant tolerance. Transplantation 95, 192\u2013202 (2013).","journal-title":"Transplantation"},{"key":"466_CR195","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1111\/j.1432-2277.2010.01095.x","volume":"23","author":"I Puig-Pey","year":"2010","unstructured":"Puig-Pey, I. et al. Characterization of \u03b3\u03b4 T cell subsets in organ transplantation. Transpl. Int. 23, 1045\u20131055 (2010).","journal-title":"Transpl. Int."},{"key":"466_CR196","doi-asserted-by":"publisher","first-page":"4458","DOI":"10.1182\/blood-2008-06-165506","volume":"113","author":"AB Pillai","year":"2009","unstructured":"Pillai, A. B., George, T. I., Dutt, S. & Strober, S. Host natural killer T cells induce an interleukin-4-dependent expansion of donor CD4+CD25+Foxp3+ T regulatory cells that protects against graft-versus-host disease. Blood 113, 4458\u20134467 (2009).","journal-title":"Blood"},{"key":"466_CR197","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1182\/blood-2011-08-371948","volume":"119","author":"D Hongo","year":"2012","unstructured":"Hongo, D., Tang, X., Dutt, S., Nador, R. G. & Strober, S. Interactions between NKT cells and Tregs are required for tolerance to combined bone marrow and organ transplants. Blood 119, 1581\u20131589 (2012).","journal-title":"Blood"},{"key":"466_CR198","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1182\/blood-2016-07-723015","volume":"129","author":"D Hongo","year":"2017","unstructured":"Hongo, D., Tang, X., Zhang, X., Engleman, E. G. & Strober, S. Tolerogenic interactions between CD8+ dendritic cells and NKT cells prevent rejection of bone marrow and organ grafts. Blood 129, 1718\u20131728 (2017).","journal-title":"Blood"},{"key":"466_CR199","doi-asserted-by":"publisher","first-page":"2823","DOI":"10.1001\/jama.296.23.2823","volume":"296","author":"CM Vajdic","year":"2006","unstructured":"Vajdic, C. M. et al. Cancer incidence before and after kidney transplantation. JAMA 296, 2823\u20132831 (2006).","journal-title":"JAMA"},{"key":"466_CR200","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4103\/jrms.JRMS_817_17","volume":"23","author":"M Matinfar","year":"2018","unstructured":"Matinfar, M., Shahidi, S. & Feizi, A. Incidence of nonmelanoma skin cancer in renal transplant recipients: a systematic review and meta-analysis. J. Res. Med. Sci. 23, 14 (2018).","journal-title":"J. Res. Med. Sci."},{"key":"466_CR201","doi-asserted-by":"publisher","DOI":"10.4161\/onci.27572","volume":"3","author":"JP Fisher","year":"2014","unstructured":"Fisher, J. P., Heuijerjans, J., Yan, M., Gustafsson, K. & Anderson, J. \u03b3\u03b4 T cells for cancer immunotherapy: a systematic review of clinical trials. Oncoimmunology 3, e27572 (2014).","journal-title":"Oncoimmunology"},{"key":"466_CR202","doi-asserted-by":"publisher","first-page":"670827","DOI":"10.3389\/fimmu.2021.670827","volume":"12","author":"E Billon","year":"2021","unstructured":"Billon, E. et al. Soluble BTN2A1 is a potential prognosis biomarker in pre-treated advanced renal cell carcinoma. Front. Immunol. 12, 670827 (2021).","journal-title":"Front. Immunol."},{"key":"466_CR203","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1016\/S0959-8049(03)00625-7","volume":"39","author":"B Krone","year":"2003","unstructured":"Krone, B. et al. Impact of vaccinations and infectious diseases on the risk of melanoma\u2013evaluation of an EORTC case-control study. Eur. J. Cancer 39, 2372\u20132378 (2003).","journal-title":"Eur. J. Cancer"},{"key":"466_CR204","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1158\/0008-5472.CAN-08-3037","volume":"69","author":"C Devaud","year":"2009","unstructured":"Devaud, C. et al. Antitumor activity of \u03b3\u03b4 T cells reactive against cytomegalovirus-infected cells in a mouse xenograft tumor model. Cancer Res. 69, 3971\u20133978 (2009).","journal-title":"Cancer Res."},{"key":"466_CR205","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1681\/ASN.2008101072","volume":"21","author":"L Couzi","year":"2010","unstructured":"Couzi, L. et al. Cytomegalovirus-induced \u03b3\u03b4 T cells associate with reduced cancer risk after kidney transplantation. J. Am. Soc. Nephrol. 21, 181\u2013188 (2010).","journal-title":"J. Am. Soc. Nephrol."},{"key":"466_CR206","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/sj.bmt.1705650","volume":"39","author":"KT Godder","year":"2007","unstructured":"Godder, K. T. et al. Long term disease-free survival in acute leukemia patients recovering with increased \u03b3\u03b4 T cells after partially mismatched related donor bone marrow transplantation. Bone Marrow Transpl. 39, 751\u2013757 (2007).","journal-title":"Bone Marrow Transpl."},{"key":"466_CR207","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1182\/blood-2010-08-304121","volume":"118","author":"AH Elmaagacli","year":"2011","unstructured":"Elmaagacli, A. H. et al. Early human cytomegalovirus replication after transplantation is associated with a decreased relapse risk: evidence for a putative virus-versus-leukemia effect in acute myeloid leukemia patients. Blood 118, 1402\u20131412 (2011).","journal-title":"Blood"},{"key":"466_CR208","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1681\/ASN.2013040332","volume":"24","author":"CY Lin","year":"2013","unstructured":"Lin, C. Y. et al. Pathogen-specific local immune fingerprints diagnose bacterial infection in peritoneal dialysis patients. J. Am. Soc. Nephrol. 24, 2002\u20132009 (2013). The first study to demonstrate that different types of bacterial peritonitis can be distinguished based on local pathogen-specific biomarker signatures on the day of presentation with acute symptoms, implicating human V\u03b39V\u03b42 T cells in the response.","journal-title":"J. Am. Soc. Nephrol."},{"key":"466_CR209","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.kint.2017.01.017","volume":"92","author":"J Zhang","year":"2017","unstructured":"Zhang, J. et al. Machine-learning algorithms define pathogen-specific local immune fingerprints in peritoneal dialysis patients with bacterial infections. Kidney Int. 92, 179\u2013191 (2017).","journal-title":"Kidney Int."},{"key":"466_CR210","unstructured":"US National Library of Medicine. ClinicalTrials.gov. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03339661 (2017)."},{"key":"466_CR211","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1000407","volume":"8","author":"MC Gold","year":"2010","unstructured":"Gold, M. C. et al. Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol. 8, e1000407 (2010).","journal-title":"PLoS Biol."},{"key":"466_CR212","doi-asserted-by":"publisher","first-page":"ltab005","DOI":"10.1093\/immadv\/ltab005","volume":"1","author":"M Eberl","year":"2021","unstructured":"Eberl, M., Oldfield, E. & Herrmann, T. Immuno-antibiotics: targeting microbial metabolic pathways sensed by unconventional T cells. Immunother. Adv. 1, ltab005 (2021).","journal-title":"Immunother. Adv."},{"key":"466_CR213","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41586-020-03074-x","volume":"589","author":"KS Singh","year":"2020","unstructured":"Singh, K. S. et al. IspH inhibitors kill Gram-negative bacteria and mobilize immune clearance. Nature 589, 597\u2013602 (2020). A study demonstrating the dual action of inhibitors of HMB-PP reductase as \u2018immuno-antibiotics\u2019 with direct antimicrobial activity against multidrug-resistant bacteria and at the same time harnessing V\u03b39V\u03b42 T cells against those bacteria.","journal-title":"Nature"},{"key":"466_CR214","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.3389\/fimmu.2018.01601","volume":"9","author":"JL Blazquez","year":"2018","unstructured":"Blazquez, J. L., Benyamine, A., Pasero, C. & Olive, D. New insights into the regulation of \u03b3\u03b4 T cells by BTN3A and other BTN\/BTNL in tumor immunity. Front. Immunol. 9, 1601 (2018).","journal-title":"Front. Immunol."},{"key":"466_CR215","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/imm.13132","volume":"159","author":"L Raffray","year":"2020","unstructured":"Raffray, L., Burton, R. J., Baker, S. E., Morgan, M. P. & Eberl, M. Zoledronate rescues immunosuppressed monocytes in sepsis patients. Immunology 159, 88\u201395 (2020).","journal-title":"Immunology"},{"key":"466_CR216","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1093\/cid\/ciy549","volume":"68","author":"C Smith","year":"2019","unstructured":"Smith, C. et al. Autologous adoptive T-cell therapy for recurrent or drug-resistant cytomegalovirus complications in solid organ transplant recipients: a single-arm open-label phase I clinical trial. Clin. Infect. Dis. 68, 632\u2013640 (2019).","journal-title":"Clin. Infect. Dis."},{"key":"466_CR217","doi-asserted-by":"publisher","first-page":"5795","DOI":"10.1158\/1078-0432.CCR-16-0597","volume":"22","author":"AR Almeida","year":"2016","unstructured":"Almeida, A. R. et al. Delta One T cells for immunotherapy of chronic lymphocytic leukemia: clinical-grade expansion\/differentiation and preclinical proof of concept. Clin. Cancer Res. 22, 5795\u20135804 (2016). A pioneering study that develops a robust and highly reproducible clinical grade method for selective and large-scale expansion and differentiation of cytotoxic human V\u03b41+ T cells, ready to use for adoptive immunotherapy.","journal-title":"Clin. Cancer Res."},{"key":"466_CR218","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1084\/jem.20052369","volume":"203","author":"SD Gadola","year":"2006","unstructured":"Gadola, S. D. et al. Structure and binding kinetics of three different human CD1d-\u03b1-galactosylceramide-specific T cell receptors. J. Exp. Med. 203, 699\u2013710 (2006).","journal-title":"J. Exp. Med."},{"key":"466_CR219","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10570","volume":"7","author":"J Le Nours","year":"2016","unstructured":"Le Nours, J. et al. Atypical natural killer T-cell receptor recognition of CD1d-lipid antigens. Nat. Commun. 7, 10570 (2016).","journal-title":"Nat. Commun."},{"key":"466_CR220","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/ni.2630","volume":"14","author":"I Van Rhijn","year":"2013","unstructured":"Van Rhijn, I. et al. A conserved human T cell population targets mycobacterial antigens presented by CD1b. Nat. Immunol. 14, 706\u2013713 (2013).","journal-title":"Nat. Immunol."},{"key":"466_CR221","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aao2556","volume":"3","author":"MJ Harriff","year":"2018","unstructured":"Harriff, M. J. et al. MR1 displays the microbial metabolome driving selective MR1-restricted T cell receptor usage. Sci. Immunol. 3, eaao2556 (2018).","journal-title":"Sci. Immunol."},{"key":"466_CR222","doi-asserted-by":"publisher","first-page":"140706","DOI":"10.1172\/JCI140706","volume":"131","author":"RN Cotton","year":"2021","unstructured":"Cotton, R. N. et al. Human skin is colonized by T cells that recognize CD1a independently of lipid. J. Clin. Invest. 131, 140706 (2021).","journal-title":"J. Clin. Invest."},{"key":"466_CR223","doi-asserted-by":"publisher","first-page":"22944","DOI":"10.1073\/pnas.2010545117","volume":"117","author":"JF Reijneveld","year":"2020","unstructured":"Reijneveld, J. F. et al. Human \u03b3\u03b4 T cells recognize CD1b by two distinct mechanisms. Proc. Natl Acad. Sci. USA 117, 22944\u201322952 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"466_CR224","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41590-018-0065-7","volume":"19","author":"KS Wun","year":"2018","unstructured":"Wun, K. S. et al. T cell autoreactivity directed toward CD1c itself rather than toward carried self lipids. Nat. Immunol. 19, 397\u2013406 (2018).","journal-title":"Nat. Immunol."},{"key":"466_CR225","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1086\/322843","volume":"184","author":"X Lafarge","year":"2001","unstructured":"Lafarge, X. et al. Cytomegalovirus infection in transplant recipients resolves when circulating \u03b3\u03b4 T lymphocytes expand, suggesting a protective antiviral role. J. Infect. Dis. 184, 533\u2013541 (2001).","journal-title":"J. Infect. Dis."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-021-00466-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-021-00466-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-021-00466-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,5]],"date-time":"2023-02-05T19:20:02Z","timestamp":1675624802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-021-00466-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,26]]},"references-count":225,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["466"],"URL":"https:\/\/doi.org\/10.1038\/s41581-021-00466-8","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,26]]},"assertion":[{"value":"13 July 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}